TY - JOUR
T1 - Glioblastoma and ABO blood groups
T2 - Further evidence of an association between the distribution of blood group antigens and brain tumours
AU - Allouh, Mohammed Z.
AU - Al Barbarawi, Mohammed M.
AU - Hiasat, Mohammad Y.
AU - Al-Qaralleh, Mohammed A.
AU - Ababneh, Emad I.
N1 - Publisher Copyright:
© 2017 SIMTI Servizi Srl.
PY - 2017
Y1 - 2017
N2 - Background. Glioblastoma is a highly malignant brain tumour that usually leads to death. Several studies have reported a link between the distribution of ABO blood group antigens and a risk of developing specific types of cancer, although no consensus has been reached. This study aims to investigate the relationship between the distribution of ABO blood group antigens and the incidence of glioblastoma. Materials and methods. The study cohort consisted of 115 glioblastoma patients who were diagnosed at King Abdullah University Hospital, Jordan, between 2004 and 2015. Three different patient populations made up three control groups and these were selected from among patients at the same institution between 2014 and 2015 as follows: 3,847 healthy blood donors, 654 accidental trauma patients admitted to the Departments of Neurosurgery and Orthopaedics, and 230 age- and sexmatched control subjects recruited blindly from the Departments of Paediatrics and Internal Medicine. Results. There was a significant association between the distribution of ABO blood group antigens and the incidence of glioblastoma. Post hoc residual analysis revealed that individuals with group A had a higher than expected chance of developing glioblastoma, while individuals with group O had a lower than expected chance. Furthermore, individuals with group A were found to be at a 1.62- to 2.28-fold increased risk of developing glioblastoma compared to individuals with group O. Discussion. In the present study, we demonstrate that, in Jordan, individuals with group A have an increased risk of developing glioblastoma, while individuals with group O have a reduced risk. These findings suggest that the distribution of ABO blood group antigens is associated with a risk of brain tumours and may play an important role in their development. However, further clinical and experimental investigations are required to confirm this association.
AB - Background. Glioblastoma is a highly malignant brain tumour that usually leads to death. Several studies have reported a link between the distribution of ABO blood group antigens and a risk of developing specific types of cancer, although no consensus has been reached. This study aims to investigate the relationship between the distribution of ABO blood group antigens and the incidence of glioblastoma. Materials and methods. The study cohort consisted of 115 glioblastoma patients who were diagnosed at King Abdullah University Hospital, Jordan, between 2004 and 2015. Three different patient populations made up three control groups and these were selected from among patients at the same institution between 2014 and 2015 as follows: 3,847 healthy blood donors, 654 accidental trauma patients admitted to the Departments of Neurosurgery and Orthopaedics, and 230 age- and sexmatched control subjects recruited blindly from the Departments of Paediatrics and Internal Medicine. Results. There was a significant association between the distribution of ABO blood group antigens and the incidence of glioblastoma. Post hoc residual analysis revealed that individuals with group A had a higher than expected chance of developing glioblastoma, while individuals with group O had a lower than expected chance. Furthermore, individuals with group A were found to be at a 1.62- to 2.28-fold increased risk of developing glioblastoma compared to individuals with group O. Discussion. In the present study, we demonstrate that, in Jordan, individuals with group A have an increased risk of developing glioblastoma, while individuals with group O have a reduced risk. These findings suggest that the distribution of ABO blood group antigens is associated with a risk of brain tumours and may play an important role in their development. However, further clinical and experimental investigations are required to confirm this association.
KW - ABO blood group system
KW - Brain tumours
KW - Cancer
KW - Glioblastoma
UR - http://www.scopus.com/inward/record.url?scp=85031927157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031927157&partnerID=8YFLogxK
U2 - 10.2450/2016.0041-16
DO - 10.2450/2016.0041-16
M3 - Article
C2 - 27416574
AN - SCOPUS:85031927157
SN - 1723-2007
VL - 15
SP - 543
EP - 547
JO - Blood Transfusion
JF - Blood Transfusion
IS - 6
ER -
